Discussion
Analyses of CT scans over the course of one year can help to predict long-term outcomes among people with idiopathic pulmonary fibrosis (IPF) who are taking pirfenidone, marketed in the U.S. as Esbriet and also available as generics. Changes in these imaging scan data were found to be…